Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment–Related Early Diastolic Dysfunction
Diastolic dysfunction (DD) was reported to precede heart failure (HF) in patients with cancer who were treated with chemotherapy. We aimed at defining risk versus dose relationships and risk predictors in patients with cancer treated mainly with anthracyclines. Data from 67 patients without comorbid...
Main Authors: | Camilli, M. (Author), Mangiacapra, F. (Author), Menna, P. (Author), Minotti, G. (Author), Reggiardo, G. (Author), Salvatorelli, E. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Pharmacology and Experimental Therapy
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.
by: Ana Garcia-Alvarez, et al.
Published: (2010-01-01) -
Use of B-Natriuretic Peptide in detecting diastolic dysfunction in hypertensive patients
by: Surendra, et al.
Published: (2014-11-01) -
Association of N- terminal pro brain natriuretic peptide with echocardiographic measures of diastolic dysfunction in cirrhosis
by: Ajmera Jail Singh, et al.
Published: (2020-01-01) -
Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides
by: Poccia Gianfranco, et al.
Published: (2010-12-01) -
Β-Natriuretic Peptide Level as a Predictor for the Severity of LV Dysfunction
by: Tharwet H. Nasser, et al.
Published: (2008-01-01)